ArticleBMC cancer2026
MRI radiomics and
Article in BMC cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTo evaluate treatment response in hepatocellular carcinoma (HCC) following Yttrium-90 ( MATERIALS AND
methodsThis retrospective study included 57 patients with pathologically confirmed HCC. All patients underwent CE-MRI within 4-6 weeks before
resultsBased on mRECIST criteria, 32 patients were classified as responders (all partial response), while 25 were non-responders (20 stable disease, 5 progressive disease). 24-hour average absorbed dose is independent predictive factors for treatment response (OR = 1.06, p = 0.006). The combined model, incorporating clinical characteristics and MRI-derived radiomic features, achieved a sensitivity of 88% (28/32) [95% CI, 71%-96%], specificity of 68% (17/25) [95% CI, 46%-85%], and accuracy of 79% (45/57) [95% CI, 66%-89%].
conclusionThe integration of pre-treatment CE-MRI radiomics with post-treatment
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.